Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer. [electronic resource]
Producer: 20111207Description: 4022-8 p. digitalISSN:- 1527-7755
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Calgranulin B -- metabolism
- Dose-Response Relationship, Drug
- Double-Blind Method
- Humans
- Male
- Middle Aged
- Molecular Targeted Therapy -- methods
- Neoplasm Metastasis
- Neoplasms, Hormone-Dependent -- drug therapy
- Orchiectomy
- Placebos
- Prostatic Neoplasms -- drug therapy
- Quinolines -- therapeutic use
- Quinolones
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.